bortezomib,azacitidine
bms,emergent biosolutions
['azacitidine,(-oral azaci),(-azacitidine oral)', 'fil,veral,12', 'dlbcl', 'oracle study', 'lymphoma', 'lymsm', 'cc-486', 'ptcl', 'emergent ']
congress | #ash22 presents final analysis of the phase iii oracle study of azacytidine in pts with r/r angioimmunoblastic t-cell #lymphoma. the primary endpoint was not met, however the drug showed a favorable safety profile and was associated with prolonged os. #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm